ORI Capital is a venture capital firm founded in 2015. Our Funds invest in innovative early-stage biotech companies globally, in the areas of diagnostics, drug delivery, and therapeutics focused on the disease areas with the highest mortality rates: cancer, cardiovascular and neurodegenerative diseases.
An Introduction to ORI Capital
HKFSDC Hong Kong Success Stories Series - Hi Beautiful Minds (ORI Capital)
Simone Song, Founder of ORI Capital shares with Laurence Li, Chairman of FSDC her beautiful evolution from tumor battling to carrying out investment for saving lives, with scientific inspiration and the help of both Artificial and Human Intelligence.